A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/13/2011	WO2011049309A3 Pharmaceutical composition with both immediate and extended release characteristics
10/13/2011	WO2011047378A9 Methods and compositions for novel liquid crystal delivery systems
10/13/2011	WO2010091822A3 N-hydroxylated amidine-, guanidine- and/or aminohydrazone-type prodrugs for application on the skin
10/13/2011	US20110251294 Fast recovery of thixotropy by organogels with low molecular weight gelators
10/13/2011	US20110251265 Polyamine-containing polymers and methods of synthesis and use
10/13/2011	US20110251244 Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient
10/13/2011	US20110251146 Topical antifungal composition
10/13/2011	US20110251136 Glue composition for lung volume reduction
10/13/2011	US20110251125 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/13/2011	US20110250299 Organogel compositions and processes for producing
10/13/2011	US20110250284 Nanoparticles for Use as Synthetic Platelets and Therapeutic Agent Delivery Vehicles
10/13/2011	US20110250271 Spaced drug delivery system
10/13/2011	US20110250263 Protein and nucleic acid delivery vehicles, components and mechanisms thereof
10/13/2011	US20110250262 Method for producing liposome and method for dissolving cholesterol
10/13/2011	US20110250257 Fibrous tissue sealant and method of using same
10/13/2011	US20110250241 Injection-moulded water-soluble container
10/13/2011	US20110250240 Immune enhancing compositions and methods of use thereof
10/13/2011	US20110250228 Compositions and Methods for Identifying and Targeting Cancer Cells of Alimentary Canal Origin
10/13/2011	US20110250174 Stable immunogenic product comprising antigenic heterocomplexes
10/13/2011	US20110250163 Mono- and di-peg il-10 production; and uses
10/13/2011	US20110250153 Oligomeric biosurfactants in dermatocosmetic compositions
10/13/2011	US20110250151 Cold process water soluble wax containing powders
10/13/2011	CA2795746A1 Miniature ingestible device
10/13/2011	CA2795734A1 Tnf-.alpha. binding proteins
10/13/2011	CA2795686A1 Biocompatible poly(amic acid) and method of preparation thereof
10/13/2011	CA2795498A1 Cell poration
10/13/2011	CA2795289A1 Methods and compositions for enhanced delivery of compounds
10/13/2011	CA2795264A1 Glycomimetic compounds and methods to inhibit infection by hiv
10/13/2011	CA2794328A1 Compositions and methods for improved retention of a pharmaceutical composition at a local administration site
10/13/2011	CA2792942A1 Novel single chemical entities and methods for delivery of oligonucleotides
10/13/2011	CA2788732A1 Easily dosable solid preparation
10/12/2011	EP2374876A2 Therapy for alpha-galactosidase a deficiency
10/12/2011	EP2374825A1 Photodynamic therapeutic agent showing accumulation of cell-specific functions
10/12/2011	EP2374481A2 Novel reagents and method for conjugating biological molecules
10/12/2011	EP2374480A2 Mutli-drug ligand conjugates
10/12/2011	EP2374479A2 Controlled-release composition for producing sustained-release preparation containing udenafil
10/12/2011	EP2374478A1 Nsaids-induced gastrointestinal mucosal disorder alleviator and manufacturing method thereof
10/12/2011	EP2374477A1 Antigen delivery vectors and constructs
10/12/2011	EP2374473A1 Dimensional analysis of saccharide conjugates with GPC & SEC-MALS
10/12/2011	EP2374450A1 Flupentixol compositions
10/12/2011	EP2374449A2 Composition including at least one aqueous phase and at least one oil phase including ivermectin
10/12/2011	EP2374448A1 Oral film formulation
10/12/2011	EP2373675A2 Thiol-functionalising reagents and their uses
10/12/2011	EP2373348A1 Delivery system for delivery of a substance into the oral cavity
10/12/2011	EP2373347A2 Modification of nucleic acid vectors with polymers comprising charged quaternary amino groups
10/12/2011	EP2373346A2 Ibuprofen for topical administration
10/12/2011	EP2373345A2 Biocompatible polysaccharide-based hydrogels
10/12/2011	EP2373344A1 Combined drug administration
10/12/2011	EP2373343A1 Immunocytokines for tumour therapy with chemotherapeutic agents
10/12/2011	EP2373304A1 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
10/12/2011	EP2373295A2 Steroidal compositions
10/12/2011	EP2373294A1 Clostridial toxin pharmaceutical compositions
10/12/2011	EP2373293A2 Compositions with reduced dimer formation
10/12/2011	EP2373289A2 Stable perfluorocarbon emulsion for use as an artificial oxygen carrier
10/12/2011	EP2373287A1 Extrudate having spicular active substances
10/12/2011	EP2373166A2 Antimicrobial compositions
10/12/2011	EP1525884B1 Aqueous liquid preparations and light-stabilized aqueous liquid preparations
10/12/2011	EP1430098B1 Gel matrix consisting of polyacrylic acid and polyvinyl pyrrolidone
10/12/2011	EP1263471B1 Antimicrobial compounds and formulations
10/12/2011	CN1980638B Compositions and methods for stabilizing lipid based adjuvant formulations using glycolipids
10/12/2011	CN102216334A Polysaccharides containing carboxyl functional groups substituted by a hydrophobic alcohol derivative
10/12/2011	CN102216310A Novel prostaglandin e1 derivative, and nanoparticle having same encapsulated therein
10/12/2011	CN102215950A Ceramide dispersion, and process for producing same
10/12/2011	CN102215876A Method for the treatment of radiation-induced neutropenia by administration of a multi-pegylated granulocyte colony stimulating factor (g-csf) variant
10/12/2011	CN102215875A Sustained drug delivery system
10/12/2011	CN102215874A Polymeric delivery systems for active agents
10/12/2011	CN102215873A Dendritic cell modulatory molecule
10/12/2011	CN102215832A Pharmaceutical formulation between jasmonates and it derivatives and nanocarries or microcarri es
10/12/2011	CN102215830A Encapsulation of biologically active agents
10/12/2011	CN102215825A Directly compressible granular microcrystalline cellulose based excipient, manufacturing process and use thereof
10/12/2011	CN102215822A Novel composition based on gamma-hydroxybutyric acid
10/12/2011	CN102215817A Pharmaceutical composition
10/12/2011	CN102215690A Antimicrobial compositions
10/12/2011	CN102212595A Preparation method and application of water-soluble nano grain polysaccharide
10/12/2011	CN102212512A Pegylated staphylokinase mutant, and preparation method and application thereof
10/12/2011	CN102212198A Double-arm star polylactic acid-polydimethylaminoethyl methacrylate amphiphilic block copolymer and preparation method thereof
10/12/2011	CN102212197A Hyperbranched star polylactic acid-polydimethylaminoethyl methacrylate amphiphilic block copolymer and preparation method thereof
10/12/2011	CN102212191A Amine-terminated polyether and continuous preparation method thereof
10/12/2011	CN102212178A Pentablock copolymer with temperature and pH dual sensitivity, and preparation method and application thereof
10/12/2011	CN102212140A Preparation of VEGF165 (vascular endothelial growth factor 165) analogue
10/12/2011	CN102212127A Glucagon-like peptide-2 poly(ethylene glycol) conjugate, and preparation method and application thereof
10/12/2011	CN102212116A Acetylcholine receptor mediated brain-targeted polypeptide and application thereof
10/12/2011	CN102212111A Micromolecule polypeptide and micromolecule polypeptide liposome as well as applications thereof
10/12/2011	CN102212019A Branched water-soluble polymers and their conjugates
10/12/2011	CN102211753A Composite material having multiple characteristics in surface and preparation method thereof
10/12/2011	CN102211008A Detachable T-shaped microchannel device and method for preparing monodisperse polymer microspheres by same
10/12/2011	CN102210872A Polyethylene glycol modified peptide pharmaceutical formulation and preparation method thereof
10/12/2011	CN102210871A Pharmaceutical carrier of slow-release medicine
10/12/2011	CN102210870A Liposome composite phospholipid capable of adjusting phase-transition temperature and application thereof
10/12/2011	CN102210869A Application of tetrahydropyrimidine and derivatives thereof in preparing percutaneous absorption enhancers
10/12/2011	CN102210868A Application of tetrahydropyrimidine and derivatives thereof in preparing oral absorption enhancers
10/12/2011	CN102210867A pH reversible response mesoporous silicon oxide composite medicament-carrying system, preparation method thereof and application thereof
10/12/2011	CN102210866A Oral preparation for slowing down absorption of alpha-glycosidase inhibitor and enhancing hypoglycemic drug effect
10/12/2011	CN102210864A Formula of medicament for treating non-infectious ocular inflammations, and inhibiting corneal neovascularization and anti-rejection reaction generated after corneal grafting
10/12/2011	CN102210853A Method for preparing liposome containing EGFs (Epidermal Growth Factors) and transdermal short peptide fusion proteins, for controlling diabetic foot gangrene
10/12/2011	CN102210849A Preparation of cyclosporine A nano-particle eye drop
10/12/2011	CN102210773A Chinese medicinal cataplasm for treating infantile pneumonia, preparation method thereof and application thereof
10/12/2011	CN102210747A Hypoglycemic pharmaceutical preparation and preparation method thereof
10/12/2011	CN102210746A Cream medicine composition and preparation method thereof
10/12/2011	CN102210739A Method for extracting total saponins and total flavonoids from alfalfa and preparation method thereof

1 ... 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 ... 1712